Table 2.
Clinical characteristics of epilepsy groups
| Epilepsy with psychosis | Matched epilepsy | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| No | Gender | Age | Seizure Type | Focus | Antipsychotic medication | gender | age | Seizure Type | Focus |
| 1 | M | 45 | partial | bilateral temporal | Risperidone 6 mg | M | 47 | partial | probably bilateral temporal |
| 2 | M | 37 | partial | bilateral temporal | Haloperidol 9 mg | M | 44 | partial | right temporal |
| 3 | F | 37 | partial | bilateral temporal | Olanzapine 20 mg | F | 38 | partial | bilateral temporal |
| 4 | F | 61 | partial | bilateral temporal | none | F | 58 | partial | probably bilateral temporal |
| 5 | F | 39 | partial | bilateral temporal | Quetiapine 50 mg | F | 35 | partial | bilateral temporal |
| 6 | M | 35 | partial | left temporal | Risperidone 1 mg | M | 34 | partial | bilateral temporal |
| 7 | F | 40 | partial | right temporal | none | F | 42 | partial | right temporal |
| 8 | F | 39 | partial | right temporal | Olanzapine 5 mg | F | 38 | partial | bilateral temporal |
| 9 | F | 43 | partial | right temporal | Propericiazine 25 mg | F | 44 | partial | right temporal |
| 10 | F | 37 | partial | right temporal | none | F | 33 | partial | bilateral temporal |
| 11 | F | 20 | partial | unknown | none | F | 17 | partial | unknown |
| 12 | M | 30 | partial | probably bilateral temporal | Olanzapine 5 mg | M | 28 | partial | left temporal |
| 13 | F | 31 | generalized | none | F | 30 | generalized | ||
| 14 | M | 26 | generalized | Quetiapine 300 mg, Propericiazine 50 mg | M | 23 | generalized |